Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Portugal

 

Portuguese competition authority goes after labs

Portugal’s competition authority (AdC) has opened an investigation into collusion it suspects took place between several of the country’s major labs groups during the years 2016 and 2022. The accused groups include Affidea, Synlab and Unilabs subsidiaries.

Eugin enters Portugal

Spain-based fertility provider Eugin Group, part of Germany-based hospital group Fresenius Helios, is entering the Portuguese market.

Affidea subsidiary IMI denies cartel involvement, whilst Unilabs accepts fine

Portugal’s competition authority has accused the country's four largest teleradiology groups of involvement in a cartel for public hospital teleradiology tenders during the years 2015 to 2018. The companies involved include Unilabs subsidiary Dr. Campos Costa, which has admitted involvement, and Affidea subsidiary Imagens Médicas Integradas, which denies involvement.

Orpea pledges to pay in full as restructuring rumours continue

French elderly care giant Orpea continues to hit the headlines for all the wrong reasons. Over the last week, dozens of facilities were raided by the French authorities, talk continues to be rife about restructuring and potential exits, and contrary to previous assertions HBI understands the group now intends to pay back the full €56m owed to the state.

Lusiadas deal still on as seller carries cost of muti-million fine

The planned acquisition of Lusiadas Saude, Portugal's third largest hospital group, by France's third largest hospital group Vivalto Sante, will not be impacted by the €34.2m fine that has been handed to Lusiadas by Portugal's competition authority.

KKR may switch to private credit to finance IVI RMA takeover

Facing an increasingly volatile market, American buyout / investment firm KKR may switch to direct lenders to finance its acquisition of fertility company IVI RMA Global, despite agreeing €800m of underwritten financing from four investment banks.

Portuguese hospital groups face €191 million fine

The Autorldade da Concorrencia (AdC), the Portuguese Competition Authority, has sanctioned and imposed fines of €191 million on several private hospital groups and the Portuguese Private Hospitals Association (APHP).

Vivalto Sante goes international with expansion into Portugal and Switzerland

Vivalto Sante, the third largest for-profit hospital group in France, is joining the likes of Fresenius, Ramsay and Mediclinic as it becomes the latest member of the highly select club of multinational hospital groups. As well as having bought a chain of three clinics in Switzerland, it is buying Lusiadas Saude, the third largest hospital group in Portugal. CEO Daniel Caille tells HBI that the decision to go international has nothing to do with opportunities for consolidation within the French market drying up.

Find Us